Stocktoria
Aclaris Therapeutics, Inc. ACRS
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2015-10-07
Aclaris Therapeutics, Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Mehra Anand | director | 2026-06-05 | Option exercise | 11,580 | — |
| SCHIFF ANDREW N | director | 2026-06-05 | Option exercise | 11,580 | — |
| Humphries William D. | director | 2026-06-05 | Option exercise | 11,580 | — |
| Molineaux Christopher P. | director | 2026-06-05 | Option exercise | 11,580 | — |
| MILANO VINCENT | director | 2026-06-05 | Option exercise | 11,580 | — |
| GOWEN MAXINE | director | 2026-06-05 | Option exercise | 11,580 | — |
| Hall Jesse Wayne | Chief Medical Officer | 2026-05-01 | Option exercise | 36,375 | — |
| Hall Jesse Wayne | Chief Medical Officer | 2026-05-01 | Tax withheld | 9,330 | $4.41 |
Source: SEC EDGAR filings · CIK 0001557746 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.